Edition:
United States

INSYS Therapeutics Inc (INSY.OQ)

INSY.OQ on NASDAQ Stock Exchange Global Market

7.04USD
23 Apr 2018
Change (% chg)

$0.01 (+0.14%)
Prev Close
$7.03
Open
$7.09
Day's High
$7.37
Day's Low
$6.90
Volume
105,995
Avg. Vol
288,642
52-wk High
$15.01
52-wk Low
$4.10

Chart for

About

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products. The Company's product Subsys, is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients and a single-use product that delivers fentanyl, an opioid... (more)

Overall

Beta: 1.05
Market Cap(Mil.): $518.88
Shares Outstanding(Mil.): 73.81
Dividend: --
Yield (%): --

Financials

  INSY.OQ Industry Sector
P/E (TTM): -- 188.22 33.60
EPS (TTM): -3.15 -- --
ROI: -130.51 -0.74 13.19
ROE: -137.00 -2.80 15.00

Ex-Insys employee in U.S. opioid case sentenced to home confinement

A former Insys Therapeutics Inc sales representative was sentenced on Monday to six months of home confinement after admitting that she participated in a scheme to pay kickbacks to two Alabama doctors to prescribe a fentanyl-based medication.

Apr 23 2018

Ex-Insys employee in U.S. opioid case sentenced to home confinement

April 23 A former Insys Therapeutics Inc sales representative was sentenced on Monday to six months of home confinement after admitting that she participated in a scheme to pay kickbacks to two Alabama doctors to prescribe a fentanyl-based medication.

Apr 23 2018

BRIEF-Insys Therapeutics To Advance Clinical Research Of Dronabinol Inhalation Using Novel Breath-Actuated Device

* INSYS THERAPEUTICS TO ADVANCE CLINICAL RESEARCH OF DRONABINOL INHALATION USING NOVEL BREATH-ACTUATED DEVICE

Apr 18 2018

Insys blasts 'incredibly broad' Maryland opioid probe subpoena

Insys Therapeutics Inc is blasting as "incredibly broad" a subpoena issued by Maryland's attorney general requiring the opioid manufacturer to search virtually all employees' emails created before December 2016.

Apr 04 2018

BRIEF-Insys Therapeutics Appoints Trudy Vanhove To Board Of Directors

* INSYS THERAPEUTICS APPOINTS TRUDY VANHOVE TO BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

Apr 02 2018

BRIEF-Insys Says Working With Authorities To Resolve Issues Related To "Inappropriate Actions" Taken By Former Employees​

* INSYS THERAPEUTICS REITERATES COMMITMENT TO COMPLIANT AND ETHICAL BUSINESS PRACTICES AND ADVANCING INNOVATIVE PRODUCT PIPELINE

Mar 19 2018

Five New York doctors charged with taking kickbacks from Insys

NEW YORK Federal prosecutors on Friday brought charges against five New York doctors accused of taking kickbacks from Insys Therapeutics Inc in exchange for prescribing the company's potent fentanyl-based cancer pain medication.

Mar 16 2018

UPDATE 3-Five New York doctors charged with taking kickbacks from Insys

NEW YORK, March 16 Federal prosecutors on Friday brought charges against five New York doctors accused of taking kickbacks from Insys Therapeutics Inc in exchange for prescribing the company's potent fentanyl-based cancer pain medication.

Mar 16 2018

Five New York doctors charged with taking kickbacks from Insys

March 16 Federal prosecutors have charged five New York doctors with taking kickbacks from Insys Therapeutics Inc in exchange for prescribing the company's potent spray version of the opioid drug fentanyl.

Mar 16 2018

Doctor in Insys opioid kickback scheme gets four years in prison

PROVIDENCE, R.I. A Rhode Island doctor was sentenced on Friday to more than four years in prison after admitting he took kickbacks from Insys Therapeutics Inc to prescribe its fentanyl-based cancer pain drug to people who did not suffer from the condition.

Mar 09 2018

Earnings vs. Estimates